Among all cardiovascular-related diseases, coronary artery disease remains the leading cause of death in western countries. The incidence and progression of heart disease is different in males and females, indicating that some protective factors are enhanced in one sex. The long term objectives of this project are to identify cellular and genetic mechanisms, regulated by sex chromosomes and gonadal hormones that affect cardiovascular disease, to improve the understanding of endogenous mechanisms of disease, and to identify sex-biased protective factors that may become targets for therapies. Previous research from our labs indicated that the number of X chromosomes causes striking differences in the response of XX and XY mice to myocardial ischemia/reperfusion injury, independent of the gonadal sex of the mice. XX mice show dramatically greater susceptibility to ischemia/reperfusion (I/R) injury, relative to XY mice, and lower post-ischemic heart contractile function. The XX vs. XY difference is attributable to the number of X chromosomes, not the presence/absence of the Y chromosome. Kdm6a is an X chromosome gene that escapes inactivation and is expressed higher in XX than XY cells, and two copies of this gene (as occurs in XX cells) cause greater I/R injury than one copy (as occurs in XY cells). The central hypothesis is that Kdm6a contributes to X chromosome dependent me /R injury via epigenetic regulation. Moreover, because estradiol is a female-enhanced factor that protects from I/R injury, one hypothesis is that estradiol regulates gene targets of KDM6A.
Aim 1 will test whether KDM6A is responsible for the XX vs. XY difference in I/R injury by measuring infarct size and heart functional recovery in mice with different copy numbers of Kdm6a (deleting one copy of Kdm6a from XX mice, and adding Kdm6a to XO mice).
Aim 2 will discover direct targets of histone demethylase KDM6A, and measure the changes in expression of genes regulated by KDM6A dosage. These studies will define a short list of genes downstream of KDM6A that can be tested to determine if they mediate KDM6A's effects on me /R injury.
Aim 3 will compare the effects of two female-specific factors, estradiol secreted from the ovary, and the presence of a second X chromosome, to establish how each factor influences the effect of the other. Genes regulated by KDM6A will be tested to determine if they are also regulated by estradiol. These studies are intended to provide a more sophisticated mechanistic understanding of the differences in I/R injury in females and males, with an eye towards discovering novel protective mechanisms that could become targets for therapy in both sexes.

Public Health Relevance

Cardiovascular diseases affect females and males differently, and thus finding factors that protect one sex may uncover novel targets for therapy. The proposed research aims to improve understanding of factors that account for sex differences in protection from coronary artery disease, using unique mouse models that offer advantages for separating the effects of gonadal hormones from the effects of the sex chromosomes. Mice with different numbers of X chromosome genes will be compared under different hormonal conditions to test their role modulating heart function and its susceptibility to myocardial injury

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Schwartz, Lisa
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Schools of Medicine
Los Angeles
United States
Zip Code
Arnold, Arthur P; Disteche, Christine M (2018) Sexual Inequality in the Cancer Cell. Cancer Res 78:5504-5505
Umar, Soban; Li, Jingyuan; Hannabass, Kyle et al. (2018) Free Fatty Acid Receptor G-protein-coupled Receptor 40 Mediates Lipid Emulsion-induced Cardioprotection. Anesthesiology 129:154-162
Umar, Soban; Cunningham, Christine M; Itoh, Yuichiro et al. (2018) The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension. Am J Respir Crit Care Med 197:952-955
Dinarello, Charles Anthony (2018) An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors. Cancer Res 78:5200-5202
Arnold, Arthur P; Cassis, Lisa A; Eghbali, Mansoureh et al. (2017) Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases. Arterioscler Thromb Vasc Biol 37:746-756
Li, Jingyuan; Ruffenach, Gregoire; Kararigas, Georgios et al. (2017) Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3? pathway. J Mol Cell Cardiol 102:108-116
Iorga, Andrea; Cunningham, Christine M; Moazeni, Shayan et al. (2017) The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 8:33
Arnold, Arthur P (2017) Y chromosome's roles in sex differences in disease. Proc Natl Acad Sci U S A 114:3787-3789
Arnold, Arthur P (2017) A general theory of sexual differentiation. J Neurosci Res 95:291-300
Arnold, Arthur P; Reue, Karen; Eghbali, Mansoureh et al. (2016) The importance of having two X chromosomes. Philos Trans R Soc Lond B Biol Sci 371:20150113

Showing the most recent 10 out of 11 publications